Press release
Veterinary Autoimmune Disease Therapeutics Market Size & Growth Insights: Emerging Trends and Future Projections 2025-2034
Veterinary Autoimmune Disease Therapeutics Market Size
What Is the Projected Growth of the Veterinary Autoimmune Disease Therapeutics Market?
The veterinary autoimmune disease therapeutics market will grow from $3.25 billion in 2024 to $3.47 billion in 2025, reflecting a CAGR of 6.8%. This growth is driven by advancements in immunology, increased pet ownership, improved diagnostic methods, the development of new drug classes, and growing awareness of pet health.
The veterinary autoimmune disease therapeutics market is projected to grow to $4.48 billion by 2029 at a CAGR of 6.6%. The growth will be driven by advancements in biotechnology, increased veterinary healare investment, rising autoimmune disease prevalence in pets, the development of novel therapeutics, and growing pet insurance adoption. Trends include personalized medicine, the use of biologics, telemedicine integration, regenerative therapies, and holistic treatments.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16208
What Are the Different Veterinary Autoimmune Disease Therapeutics Market Segments?
The veterinary autoimmune disease therapeutics market covered in this report is segmented -
1) By Therapy Type: Corticosteroids, Azathioprine, Cyclosporine, Mycophenolate, Leflunomide, Cyclophosphamide, Levothyroxine, Folic Acid, Hydroxychloroquine, Chloroquine
2) By Animal Type: Companion Animals, Livestock Animals, Other Animals
3) By Disease: Hypothyroidism, Pemphigus Disease, Canine Lupus, Auto-Immune Hemolytic Anemia, Bullous Pemphigoid, Discoid Lupus Erythematosus (DLE), Immune-Related Arthritis, Other Diseases
4) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics
Subsegments:
1) By Corticosteroids: Prednisone, Prednisolone, Dexamethasone, Methylprednisolone, Triamcinolone
2) By Azathioprine: Azathioprine Oral Tablets, Azathioprine Injectable Formulation
3) By Cyclosporine: Oral Cyclosporine (Atopica), Injectable Cyclosporine
4) By Mycophenolate: Mycophenolate Mofetil (Oral Form), Mycophenolate Sodium (Injectable Form)
5) By Leflunomide: Leflunomide Tablets (Oral), Leflunomide Injection
6) By Cyclophosphamide: Oral Cyclophosphamide, Injectable Cyclophosphamide
7) By Levothyroxine: Levothyroxine Sodium Tablets (Oral), Levothyroxine Sodium Injection
8) By Folic Acid: Folic Acid s (Oral), Injectable Folic Acid
9) By Hydroxychloroquine: Hydroxychloroquine Tablets (Oral), Hydroxychloroquine Injectable Formulation
10) By Chloroquine: Chloroquine Tablets (Oral), Chloroquine Injectable Formulation
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16208&type=smp
What Are the Primary Drivers Shaping the Veterinary Autoimmune Disease Therapeutics Market?
The increasing funding for research in veterinary medicine is expected to support the growth of the veterinary autoimmune disease therapeutics market. This funding, driven by the rising prevalence of zoonotic diseases, pet industry growth, and advances in animal health, supports the development of treatments for autoimmune diseases in animals. The National Institute of Food and Agriculture's 2024 report highlighted substantial investments in veterinary medicine, contributing to the growth of therapeutics for veterinary autoimmune diseases.
Which Companies Are Leading in the Veterinary Autoimmune Disease Therapeutics Market?
Major companies operating in the veterinary autoimmune disease therapeutics market are Pfizer Inc, Merck & Co Inc, AbbVie Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline, Takeda Pharmaceutical Company, Amgen Inc., Teva Pharmaceuticals Industries Ltd., Zoetis Inc, Boehringer Ingelheim International GmbH, Sumitomo Pharma Co. Ltd., IDEXX Laboratories Inc., Cipla Inc., Mallinckrodt Pharmaceuticals, Virbac S.A, Dechra Pharmaceuticals plc, Neogen Corporation, Vetoquinol S.A., Norbrook Laboratories Limited, Heska Corporation, Bimeda Holdings PLC, Bayer Animal Health Inc, Aratana Therapeutics Inc, Hester Biosciences Limited
What Are the Latest Developing Trends in the Veterinary Autoimmune Disease Therapeutics Market?
Companies in the veterinary autoimmune disease therapeutics market are advancing biologics and regenerative medicine. In January 2024, Biocytogen, a China-based biotechnology company, launched RenBiologics, a new sub-brand focused on developing fully human antibodies to treat kidney-related and chronic conditions, partnering with other companies for antibody-based therapeutic co-development.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/veterinary-autoimmune-disease-therapeutics-global-market-report
What Are the Top Revenue-Generating Geographies in the Veterinary Autoimmune Disease Therapeutics Market?
North America was the largest region in the veterinary autoimmune disease therapeutics market in 2023. The regions covered in the veterinary autoimmune disease therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Veterinary Autoimmune Disease Therapeutics Market?
2. What is the CAGR expected in the Veterinary Autoimmune Disease Therapeutics Market?
3. What Are the Key Innovations Transforming the Veterinary Autoimmune Disease Therapeutics Industry?
4. Which Region Is Leading the Veterinary Autoimmune Disease Therapeutics Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Veterinary Autoimmune Disease Therapeutics Market Size & Growth Insights: Emerging Trends and Future Projections 2025-2034 here
News-ID: 4046440 • Views: …
More Releases from The Business Research Company
Key Trends Reshaping the Industrial Wet Dust Collector Market: Advanced Filtrati …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Industrial Wet Dust Collector Market Size Growth Forecast: What to Expect by 2025?
In recent times, there has been a robust growth in the size of the industrial wet dust collector market. It is expected to swell from $1.89 billion in 2024 to $2 billion by 2025, showing a…
The Increasing Research And Development Investment Is Fueling The Growth Of The …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Analytical Balances And Scales Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for analytical balances and scales has consistently expanded in the past years. The market value, which sat at $0.77 billion in 2024, is predicted to rise to $0.81 billion in 2025,…
Soaring Demand Set to Propel Robot Charging Station Market to $13.31 Billion by …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Robot Charging Station Market Through 2025?
The market size for robotic charging stations has seen speedy expansion in the past few years. The market, which is projected to rise from a worth of $7.15 billion in 2024 to $8.05 billion in 2025,…
Pack Conveyors Market Growth Accelerates: Strategic Forecast Predicts $11.55 Bil …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Pack Conveyors Industry Market Size Be by 2025?
In recent years, there has been a consistent rise in the pack conveyors market size. It's projected to expand from $8.81 billion in 2024 to $9.23 billion in 2025, maintaining a compound annual growth rate (CAGR) of 4.8%.…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
